7J5-69084-37078
4 vaccinations
3 coded responses
36 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 152 / PA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-28
- 2020-12-29
- 2021-01-06
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Muscle or body achesAdult check-in
- 2021-01-14
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Injection site erythema, Injection site pain — Feeling: Good · Site: Pain, RednessFree text: Redness and pain at injection site probably started the day after injection, but I only noticed the redness yesterday because I hadnt looked until thenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-20
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-15
-
2021-09-25
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-25
- 2021-10-30
- 2021-11-06
- 2021-12-25
- 2022-03-26
-
2022-09-09
Dose 4 — Pfizer-BioNTech
- 2022-09-25
- 2022-10-09
- 2022-10-14
- 2022-10-21
-
2022-12-09
Survey response — 3 months, dose 4MedDRA: Gastroenteritis viral, Upper respiratory tract infection — Feeling: GoodFree text: Upper respiratory infection, viral gastroenteritisMedDRA releases: 2024-11 · check-in free text available
-
2023-03-12
Survey response — 6 months, dose 4MedDRA: Viral infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
| 4 | 2022-09-09 | Pfizer-BioNTech | No |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Redness and pain at injection site probably started the day after injection, but I only noticed the redness yesterday because I hadnt looked until then
Release 12 — 3 months, dose 4
Symptoms: Upper respiratory infection, viral gastroenteritis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release